Successful response to infliximab of recurrent pericardial graft versus host disease in a pediatric patient

Bone Marrow Transplant. 2013 Jan;48(1):144-5. doi: 10.1038/bmt.2012.91. Epub 2012 May 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Bone Marrow Transplantation / adverse effects
  • Child
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / physiopathology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Male
  • Pericardial Effusion / etiology
  • Pericardial Effusion / prevention & control*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Severity of Illness Index
  • Transplantation, Homologous
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab